North Rock Partners, LLC Pfizer Inc Transaction History

North Rock Partners, LLC

$1.14 Billion
Q3 2024

A detailed history of North Rock Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, North Rock Partners, LLC holds 25,102 shares of PFE stock, worth $666,709. This represents 0.06% of its overall portfolio holdings.

Number of Shares

25,102

Previous 24,605 2.02%

Holding current value

$666,709

Previous $688,000 5.52%

% of portfolio

0.06%

Previous 0.06%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$27.7 - $31.39 $13,766 - $15,600	497 Added 2.02%	25,102 $726,000
Q2 2024 Aug 06, 2024	SELL	$25.26 - $29.6 $236,433 - $277,056	-9,360 Reduced 27.56%	24,605 $688,000
Q1 2024 May 07, 2024	BUY	$25.89 - $29.73 $6,343 - $7,283	245 Added 0.73%	33,965 $942,000
Q4 2023 Feb 08, 2024	BUY	$26.13 - $33.94 $12,045 - $15,646	461 Added 1.39%	33,720 $970,000
Q3 2023 Oct 24, 2023	BUY	$32.09 - $37.51 $105,287 - $123,070	3,281 Added 10.94%	33,259 $1.1 Million
Q2 2023 Aug 02, 2023	BUY	$36.12 - $41.79 $78,669 - $91,018	2,178 Added 7.83%	29,978 $1.1 Million
Q1 2023 May 03, 2023	SELL	$39.39 - $51.28 $265,094 - $345,114	-6,730 Reduced 19.49%	27,800 $1.13 Million
Q4 2022 Feb 01, 2023	BUY	$41.75 - $54.5 $4,509 - $5,886	108 Added 0.31%	34,530 $1.77 Million
Q3 2022 Nov 02, 2022	SELL	$43.76 - $53.42 $174,777 - $213,359	-3,994 Reduced 10.4%	34,422 $1.51 Million
Q2 2022 Aug 04, 2022	BUY	$46.53 - $55.17 $125,026 - $148,241	2,687 Added 7.52%	38,416 $2.01 Million
Q1 2022 May 05, 2022	BUY	$45.75 - $56.69 $116,388 - $144,219	2,544 Added 7.67%	35,729 $1.85 Million
Q4 2021 Feb 07, 2022	BUY	$41.32 - $61.25 $251,184 - $372,338	6,079 Added 22.43%	33,185 $1.96 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $155,390 - $199,612	-3,959 Reduced 12.74%	27,106 $1.17 Million
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $209,570 - $237,408	-5,836 Reduced 15.82%	31,065 $1.22 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $438,953 - $495,051	13,107 Added 55.09%	36,901 $1.34 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $105,463 - $134,106	-3,151 Reduced 11.69%	23,794 $876,000
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $206,914 - $242,758	6,517 Added 31.9%	26,945 $989,000
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $30 - $36	1 Added 0.0%	20,428 $668,000
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $139,576 - $169,326	4,634 Added 29.34%	20,427 $668,000
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $501,028 - $715,860	-18,536 Reduced 54.0%	15,793 $515,000
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $1.76 Million - $2 Million	-53,588 Reduced 60.95%	34,329 $1.35 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $1.98 Million - $2.24 Million	60,057 Added 215.57%	87,917 $1.35 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $905,171 - $1.17 Million	27,860 New	27,860 $1 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $314,737 - $345,791	-8,393 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $322,878 - $368,116	8,393 New	8,393 $365,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.

Account

North Rock Partners, LLC Pfizer Inc Transaction History